1,176
Views
50
CrossRef citations to date
0
Altmetric
Research Articles

Drug Burden Index associated with function in community-dwelling older people in Finland: A cross-sectional study

, , , , &
Pages 458-467 | Received 16 Nov 2010, Accepted 28 Feb 2011, Published online: 15 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammed A Mohammed, Rebekah J Moles & Timothy F Chen. (2021) Factors Associated with Medication-Related Burden Quality of Life (MRB-QoL) in Community-Dwelling Adults with Long-Term Conditions: An Exploratory Study. Patient Related Outcome Measures 12, pages 55-63.
Read now
Lisa Kouladjian, Danijela Gnjidic, Timothy F Chen, Arduino A Mangoni & Sarah N Hilmer. (2014) Drug Burden Index in older adults: theoretical and practical issues. Clinical Interventions in Aging 9, pages 1503-1515.
Read now

Articles from other publishers (48)

Bonnie M. Liu, Lisa Kouladjian O'Donnell, Mitchell R. Redston, Kenji Fujita, Janani Thillainadesan, Danijela Gnjidic & Sarah N. Hilmer. (2023) Association of the Drug Burden Index ( DBI ) exposure with outcomes: A systematic review . Journal of the American Geriatrics Society.
Crossref
Hamish Jamieson, Prasad S Nishtala, Hans Ulrich Bergler, Susan K Weaver, John W Pickering, Nagham J Ailabouni, Rebecca Abey-Nesbit, Carolyn Gullery, Joanne Deely, Susan B Gee, Sarah N Hilmer & Dee Mangin. (2023) Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial. The Journals of Gerontology: Series A 78:9, pages 1692-1700.
Crossref
Kenji Fujita, Patrick Hooper, Nashwa Masnoon, Sarita Lo, Danijela Gnjidic, Christopher Etherton-Beer, Emily Reeve, Parker Magin, J. Simon Bell, Kenneth Rockwood, Lisa Kouladjian O’Donnell, Mouna Sawan, Melissa Baysari & Sarah N. Hilmer. (2023) Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study. Drugs & Aging 40:7, pages 633-642.
Crossref
Kjerstin Havnes, Kristian Svendsen, Jeanette Schultz Johansen, Anne Gerd Granas, Beate Hennie Garcia & Kjell H. Halvorsen. (2023) Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community‐dwelling older patients acutely admitted to hospital? A N orwegian registry‐based study . Pharmacoepidemiology and Drug Safety 32:6, pages 607-616.
Crossref
Teddy Novais, Christelle Prudent, Amélie Cransac, Frederic Gervais, Christelle Mouchoux, Mickael Gigan, Véronique Cahoreau, Julien Jouglen & Valérie Chamouard. (2022) Potentially inappropriate medications and anticholinergic and sedative burden in older patients with haemophilia or von Willebrand disease: The M’HEMORRH‐AGE study . Journal of Clinical Pharmacy and Therapeutics 47:6, pages 783-791.
Crossref
Yoshihiro Yoshimura, Ayaka Matsumoto & Ryo Momosaki. (2022) Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine. Progress in Rehabilitation Medicine 7:0, pages n/a.
Crossref
Roland Nnaemeka Okoro & Algoni Idris Idris. (2022) Older adults’ exposure to anticholinergic medications: Implications for pharmaceutical care for Nigerian older adults. The Journal of Medicine Access 6, pages 275508342211127.
Crossref
M. Petrovic. 2022. Geriatrie in de fysiotherapie en kinesitherapie. Geriatrie in de fysiotherapie en kinesitherapie 213 222 .
Ayse Irem Yasin, Atakan Topcu, Meysere Nur Akuc, Hacı Mehmet Türk & Pinar Soysal. (2021) A comparison of anticholinergic burden in older patients with and without cancer. Future Oncology 17:36, pages 5067-5075.
Crossref
David Mehdizadeh, Matthew Hale, Oliver Todd, Hadar Zaman, Iuri Marques, Duncan Petty, David P. Alldred, Owen Johnson, Muhammad Faisal, Peter Gardner & Andrew Clegg. (2021) Associations Between Anticholinergic Medication Exposure and Adverse Health Outcomes in Older People with Frailty: A Systematic Review and Meta-analysis. Drugs - Real World Outcomes 8:4, pages 431-458.
Crossref
Hans Wouters, Jos P. Van Campen, Marloes J. Kuitert, Lisette Kikkert, Sarah N. Hilmer, Katja Taxis, Helene G. Van der Meer & Claudine J. C. Lamoth. (2021) Anticholinergic and Sedative Medications and Dynamic Gait Parameters in Older Patients. Drugs & Aging 38:12, pages 1087-1096.
Crossref
Frederic Gervais, Virginie Dauphinot, Christelle Mouchoux & Pierre Krolak-Salmon. (2021) Exposure to Anticholinergic and Sedative Drugs and Healthcare Costs in Older Patients with Neurocognitive Disorders. Journal of Alzheimer's Disease 80:4, pages 1515-1524.
Crossref
Marta Lavrador, Ana C. Cabral, Isabel V. Figueiredo, Manuel T. Veríssimo, M. Margarida Castel-Branco & Fernando Fernandez-Llimos. (2020) Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. International Journal of Clinical Pharmacy 43:1, pages 128-136.
Crossref
Silvia Martínez Arrechea, Alexander Ferro Uriguen, Idoia Beobide Telleria, Javier González Bueno, Javier Alaba Trueba & Daniel Sevilla Sánchez. (2021) Prevalencia de prescripción de fármacos con carga anticolinérgica/sedante en adultos mayores institucionalizados con demencia. Revista Española de Geriatría y Gerontología 56:1, pages 11-17.
Crossref
Marta Lavrador, M. Margarida Castel-Branco, Ana C. Cabral, Manuel T. Veríssimo, Isabel V. Figueiredo & Fernando Fernandez-Llimos. (2021) Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes. Pharmacological Research 163, pages 105306.
Crossref
Susan J. Blalock, Chelsea P. Renfro, Jessica M. Robinson, Joel F. Farley, Jan Busby-Whitehead & Stefanie P. Ferreri. (2020) Using the Drug Burden Index to identify older adults at highest risk for medication-related falls. BMC Geriatrics 20:1.
Crossref
Kaisa R. Yrjana, Victoria L. Keevil, Roy L. Soiza, Robert N. Luben, Nicholas J. Wareham, Kay-Tee Khaw & Phyo K. Myint. (2020) Anticholinergic medication exposure predicts poor physical capability: Findings from a large prospective cohort study in England. Maturitas 142, pages 55-63.
Crossref
Susan J. Blalock, Stefanie P. Ferreri, Chelsea P. Renfro, Jessica M. Robinson, Joel F. Farley, Neepa Ray & Jan Busby‐Whitehead. (2020) Impact of STEADI‐Rx : A Community Pharmacy‐Based Fall Prevention Intervention . Journal of the American Geriatrics Society 68:8, pages 1778-1786.
Crossref
Ángela María Villalba-Moreno, Eva Rocío Alfaro-Lara & Susana Sánchez-Fidalgo. (2020) Fármacos con carga anticolinérgica: aspectos prácticos y precauciones. FMC - Formación Médica Continuada en Atención Primaria 27:7, pages 353-367.
Crossref
Elpidio Attoh-Mensah, Gilles Loggia, Pascale Schumann-Bard, Rémy Morello, Pablo Descatoire, Christian Marcelli & Chantal Chavoix. (2020) Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young–Old and Old–Old Adults. Drugs & Aging 37:4, pages 301-310.
Crossref
Karen Cardwell, Ngaire Kerse, Cristín Ryan, Ruth Teh, Simon A. Moyes, Oliver Menzies, Anna Rolleston, Joanna Broad & Carmel M. Hughes. (2020) The Association Between Drug Burden Index (DBI) and Health-Related Outcomes: A Longitudinal Study of the ‘Oldest Old’ (LiLACS NZ). Drugs & Aging 37:3, pages 205-213.
Crossref
Juliette O’Connell, Martin C. Henman, Éilish Burke, Clare Donegan, Philip McCallion, Mary McCarron & Máire O’Dwyer. (2019) Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study. BMC Geriatrics 19:1.
Crossref
Catherine J. Byrne, Caroline Walsh, Caitriona Cahir & Kathleen Bennett. (2019) Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: a cohort study. BMC Geriatrics 19:1.
Crossref
Edeltraut Kröger, Marilyn Simard, Marie-Josée Sirois, Marianne Giroux, Caroline Sirois, Lisa Kouladjian-O’Donnell, Emily Reeve, Sarah Hilmer, Pierre-Hugues Carmichael & Marcel Émond. (2018) Is the Drug Burden Index Related to Declining Functional Status at Follow-up in Community-Dwelling Seniors Consulting for Minor Injuries? Results from the Canadian Emergency Team Initiative Cohort Study. Drugs & Aging 36:1, pages 73-83.
Crossref
Eric Anson, Elizabeth Thompson, Samuel C. Karpen, Brian L. Odle, Edith Seier, John Jeka & Peter C. Panus. (2018) Visual biofeedback training reduces quantitative drugs index scores associated with fall risk. BMC Research Notes 11:1.
Crossref
Eric AnsonElizabeth ThompsonBrian L. OdleJohn JekaZachary F. WallsPeter C. Panus. (2018) Influences of Age, Obesity, and Adverse Drug Effects on Balance and Mobility Testing Scores in Ambulatory Older Adults. Journal of Geriatric Physical Therapy 41:4, pages 218-229.
Crossref
Syed Shahzad Hasan, Annita Shi Chin Liew, David Weng Kwai Chong, Kaeshaelya Thiruchelvam & Zaheer-Ud-Din Babar. (2018) Associations between Drug Burden Index, medication appropriateness and patient-reported outcomes in the community pharmacy setting in Malaysia. Drugs & Therapy Perspectives 34:9, pages 437-443.
Crossref
Catherine J Byrne, Caroline Walsh, Caitriona Cahir, Cristín Ryan, David J Williams & Kathleen Bennett. (2018) Anticholinergic and sedative drug burden in community-dwelling older people: a national database study. BMJ Open 8:7, pages e022500.
Crossref
Tomas J. Welsh, Veronika van der Wardt, Grace Ojo, Adam L. Gordon & John R. F. Gladman. (2018) Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews. Drugs & Aging 35:6, pages 523-538.
Crossref
Juliette O'Connell, Éilish Burke, Niamh Mulryan, Claire O'Dwyer, Clare Donegan, Philip McCallion, Mary McCarron, Martin C. Henman & Máire O'Dwyer. (2018) Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study. British Journal of Clinical Pharmacology 84:3, pages 553-567.
Crossref
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett & Gillian E. Caughey. (2018) Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review. Drugs & Aging 35:1, pages 43-60.
Crossref
L. M. J. Sanders, T. Hortobágyi, G. van Staveren, K. Taxis, F. Boersma, H. C. Klein, W. J. R. Bossers, C. G. Blankevoort, E. J. A. Scherder, E. A. Van der Zee & M. J. G. van Heuvelen. (2017) Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia. European Journal of Clinical Pharmacology 73:12, pages 1633-1642.
Crossref
Courtney D. Hall, Samuel C. Karpen, Brian Odle, Peter C. Panus & Zachary F. Walls. (2017) Development and evaluation of the Medication-based Index of physical Function (MedIP). Age and Ageing 46:5, pages 761-766.
Crossref
Hans Wouters, Helene van der Meer & Katja Taxis. (2016) Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. European Journal of Clinical Pharmacology 73:3, pages 257-266.
Crossref
Clare L Clarke & Miles D Witham. (2017) The Effects of Medication on Activity and Rehabilitation of Older People – Opportunities and Risks. Rehabilitation Process and Outcome 6, pages 117957271771143.
Crossref
Daniela C. Moga, Heidi Taipale, Anna-Maija Tolppanen, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Qishan Wu, Gregory A. Jicha & Danijela Gnjidic. (2016) A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer’s Disease in the US and Finland. Drugs & Aging 34:1, pages 55-65.
Crossref
Philippe Martin, Robyn Tamblyn, Sara Ahmed, Andrea Benedetti & Cara Tannenbaum. (2015) A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial. Trials 16:1.
Crossref
Tanja Mayer, Walter E Haefeli & Hanna M Seidling. (2015) Different methods, different results—how do available methods link a patient’s anticholinergic load with adverse outcomes?. European Journal of Clinical Pharmacology 71:11, pages 1299-1314.
Crossref
Carina Michalek, Martin Wehling, Jeanina Schlitzer & Helmut Frohnhofen. (2014) Effects of “Fit fOR The Aged” (FORTA) on pharmacotherapy and clinical endpoints—a pilot randomized controlled study. European Journal of Clinical Pharmacology 70:10, pages 1261-1267.
Crossref
Prasad S. Nishtala, Sujita W. Narayan, Ting Wang & Sarah N. Hilmer. (2014) Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiology and Drug Safety 23:7, pages 753-758.
Crossref
Sarah N. Hilmer, Danijela Gnjidic & Darrell R. Abernethy. (2014) Drug Burden Index for International Assessment of the Functional Burden of Medications in Older People. Journal of the American Geriatrics Society 62:4, pages 791-792.
Crossref
Danijela Gnjidic, Sarah N. Hilmer, Sirpa Hartikainen, Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen & J. Simon Bell. (2014) Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study. PLoS ONE 9:1, pages e83224.
Crossref
Danijela Gnjidic, David G Le Couteur, Sallie-Anne Pearson, Andrew J McLachlan, Rosalie Viney, Sarah N Hilmer, Fiona M Blyth, Grace Joshy & Emily Banks. (2013) High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health 13:1.
Crossref
Clare V Bostock, Roy L Soiza & Arduino A Mangoni. (2013) Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients. Therapeutic Advances in Drug Safety 4:6, pages 235-245.
Crossref
Sujita W. Narayan, Sarah N. Hilmer, Simon Horsburgh & Prasad S. Nishtala. (2013) Anticholinergic Component of the Drug Burden Index and the Anticholinergic Drug Scale as Measures of Anticholinergic Exposure in Older People in New Zealand: A Population-Level Study. Drugs & Aging 30:11, pages 927-934.
Crossref
O. Best, D. Gnjidic, S. N. Hilmer, V. Naganathan & A. J. McLachlan. (2013) Investigating polypharmacy and drug burden index in hospitalised older people. Internal Medicine Journal 43:8, pages 912-918.
Crossref
Pasi Lampela, Piia Lavikainen, J. Arturo Garcia-Horsman, J. Simon Bell, Risto Huupponen & Sirpa Hartikainen. (2013) Anticholinergic Drug Use, Serum Anticholinergic Activity, and Adverse Drug Events Among Older People: A Population-Based Study. Drugs & Aging 30:5, pages 321-330.
Crossref
J. Simon Bell, Jouni Ahonen, Piia Lavikainen & Sirpa Hartikainen. (2012) Potentially inappropriate drug use among older persons in Finland: application of a new national categorization. European Journal of Clinical Pharmacology 69:3, pages 657-664.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.